MedTrace Logo

A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

NCT01673191 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-04-05

Study results available
· View outcomes & findings →

Summary

There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.

Conditions

Interventions

DRUG

Dexamethasone intravitreal implant

DRUG

Steroid plus NSAID eye drop combination therapy

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Retinal Consultants of Arizona

    lead OTHER

Principal Investigators

  • Pravin U Dugel, MD · Retinal Consultants of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01673191 on ClinicalTrials.gov